Friday, August 09, 2019 11:24:20 AM
https://webfiles.thecse.com/fs_abattis_093018.pdf?zL28ReTpJ2NgursxxInC3Q2YpnWXufhW
Keep in mind the following:
1. This is for FY 2018 (Oct. 1 thru Sept. 30 2018) so the information at hand is very, very dated.
2. The CSE has not yet lifted the delisting or suspension order. I will speculate that they lift the delist order but may keep it suspended for further review.
3. During this time period two numbers stand out:
1. “OPERATING ACTIVITIES Net loss for the year
Adjustment for items not affecting cash:
September 30, 2018
$ (77,650,572)”. From the financials
2. Sales: $8371
In response to your statement that people who sold on the delist news will regret it - current share price is below a penny.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM